Integra LifeSciences Holdings Corporation (IART) Market Cap & Valuation Ratios
Integra LifeSciences Holdings Corporation (IART) has a market cap of $926.6M and a price-to-sales ratio of 0.6, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
IARTIntegra LifeSciences Holdings CorporationFollow IART — free
—
Price chart with a free account
- Market cap
- 926.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 24 Feb, in 123 days
Peers
medical devices · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| IART | 0.9 | — | 1.5 | 10.8 | 9.3% | +0.8% | 4% | 2% |
| PRCT | 1.1 | — | 2.9 | — | -7.4% | +23% | -34% | -77% |
| AORT | 1.1 | — | 3.0 | 31.5 | -0.8% | +16% | 4% | 2% |
| IRMD | 1.1 | 47.9 | 12.0 | 35.6 | 2.2% | +11% | 32% | 51% |
| CBLL | 1.0 | — | 9.1 | — | -5.3% | +32% | -69% | -52% |
| SIBN | 1.0 | — | 4.5 | — | -0.5% | +15% | -8% | -10% |
| QDEL | 0.9 | — | 1.4 | — | — | -2% | -31% | -17% |
| INMD | 0.9 | 9.8 | 1.3 | 5.8 | 9.5% | -6% | 23% | 19% |
| BBNX | 0.9 | — | 5.7 | — | -7.1% | +53% | -70% | -35% |
| AHCO | 0.8 | — | 0.8 | 9.0 | 11.9% | -0.4% | -4% | -4% |
| VREX | 0.8 | — | 1.2 | 10.3 | -2.6% | +5% | 8% | 8% |
| Median of these 10 | 28.9 | 2.9 | 10.3 | -0.8% | +13% | -6% | -7% |
; EV/Sales 1.5 vs. 2.9.
Growth vs. price
each dot a company · hover or tap for valuesIntegra LifeSciences Holdings Corporation — questions
- What is Integra LifeSciences Holdings Corporation's market cap?
- $926.6M.
- What is Integra LifeSciences Holdings Corporation's price-to-sales ratio?
- 0.6.
Every figure on this page comes from Integra LifeSciences Holdings Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.